First IL-6–blocking drug nears approval for rare blood disorder Nature.com However, there are few effective treatment options for people with HIV-negative MCD. Clinicians currently turn to steroids or chemotherapeutics, which can decrease symptoms of inflammation or B-cell growth but which cannot be used long term, or ... |
